Literature DB >> 18245490

Systematic high-content proteomic analysis reveals substantial immunologic changes in colorectal cancer.

Uta Berndt1, Lars Philipsen, Sebastian Bartsch, Bertram Wiedenmann, Daniel C Baumgart, Marcus Hämmerle, Andreas Sturm.   

Abstract

The immune system is a significant determinant of epithelial tumorigenesis, but its role in colorectal cancer pathogenesis is not well understood. The function of the immune system depends upon the integrity of the protein network environment, and thus, we performed MELC immunofluorescence microscopy focusing on the lamina propria. By analyzing structurally intact tissues from colorectal cancer, ulcerative colitis, and healthy colonic mucosa, we used this unique and novel highly multiplexed robotic-imaging technology, which allows visualizing dozens of proteins simultaneously, and explored the toponome in colorectal cancer mucosa for the first time. We identified 1,930 motifs that distinguish control from colorectal cancer tissue. In colorectal cancer, the number of activated T cells is increased, explained by a lack of bax, caspase-3, and caspase-8. Whereas CD4(+)CD25(+) T cells are decreased and are, other than in ulcerative colitis, not activated, cytotoxic T cells are significantly increased in colorectal cancer. Furthermore, the number of activated human lymphocyte antigen (HLA)-DR(+) T-cells is increased in colorectal cancer, pointing to an altered antigen presentation. In colorectal cancer, CD3(+)CD29(+) expression and assembly of the LFA-1 and LFA-3 receptor are differentially changed, indicating a distinct regulation of T-cell adhesion in colorectal cancer. We also identified increased numbers of natural killer and CD44(+) cells in the colorectal cancer mucosa and nuclear factor-kappaB as regulator of apoptosis in these cell populations. High-content proteomic analysis showed that colorectal cancer induces a tremendous modification of protein expression profiles in the lamina propria. Thus, topological proteomic analysis may help to unravel the role of the adaptive immune system in colorectal cancer and aid the development of new antitumor immunotherapy approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245490     DOI: 10.1158/0008-5472.CAN-07-2923

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Comprehensive site-specific whole genome profiling of stromal and epithelial colonic gene signatures in human sigmoid colon and rectal tissue.

Authors:  Jason M Knight; Eunji Kim; Ivan Ivanov; Laurie A Davidson; Jennifer S Goldsby; Meredith A J Hullar; Timothy W Randolph; Andrew M Kaz; Lisa Levy; Johanna W Lampe; Robert S Chapkin
Journal:  Physiol Genomics       Date:  2016-07-08       Impact factor: 3.107

2.  Murine whole-organ immune cell populations revealed by multi-epitope-ligand cartography.

Authors:  Jenny Eckhardt; Christian Ostalecki; Katarzyna Kuczera; Gerold Schuler; Ansgar J Pommer; Matthias Lechmann
Journal:  J Histochem Cytochem       Date:  2012-11-16       Impact factor: 2.479

3.  LFA-1 expression in a series of colorectal adenocarcinomas.

Authors:  Maria G Papas; Pantelis S Karatzas; Ioannis S Papanikolaou; Evanthia Karamitopoulou; Eumorphia M Delicha; Andreas Adler; Konstantinos Triantafyllou; Georgia-Heleni Thomopoulou; Efstratios Patsouris; Andreas C Lazaris
Journal:  J Gastrointest Cancer       Date:  2012-09

4.  Comparative Multi-Epitope-Ligand-Cartography reveals essential immunological alterations in Barrett's metaplasia and esophageal adenocarcinoma.

Authors:  Uta Berndt; Lars Philipsen; Sebastian Bartsch; Yuqin Hu; Christoph Röcken; Wiedenmann Bertram; Marcus Hämmerle; Thomas Rösch; Andreas Sturm
Journal:  Mol Cancer       Date:  2010-07-06       Impact factor: 27.401

Review 5.  Cell surface markers in colorectal cancer prognosis.

Authors:  Larissa Belov; Jerry Zhou; Richard I Christopherson
Journal:  Int J Mol Sci       Date:  2010-12-28       Impact factor: 5.923

6.  Using toponomics to characterize phenotypic diversity in alveolar macrophages from male mice treated with exogenous SP-A1.

Authors:  David S Phelps; Vernon M Chinchilli; Judith Weisz; Debra Shearer; Xuesheng Zhang; Joanna Floros
Journal:  Biomark Res       Date:  2020-02-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.